ES2003774A6 - 8 alpha -Acylaminoergoline's - Google Patents
8 alpha -Acylaminoergoline'sInfo
- Publication number
- ES2003774A6 ES2003774A6 ES8700163A ES8700163A ES2003774A6 ES 2003774 A6 ES2003774 A6 ES 2003774A6 ES 8700163 A ES8700163 A ES 8700163A ES 8700163 A ES8700163 A ES 8700163A ES 2003774 A6 ES2003774 A6 ES 2003774A6
- Authority
- ES
- Spain
- Prior art keywords
- compound
- alkyl
- formula
- alpha
- react
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 abstract 7
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 abstract 1
- -1 COOR5 Chemical group 0.000 abstract 1
- 101100440695 Dictyostelium discoideum corB gene Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 239000003176 neuroleptic agent Substances 0.000 abstract 1
- 230000000701 neuroleptic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
- C07D457/12—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR NUEVAS 8 ALFA©ACILAMINO©ERGOLINAS, DE FORMULA (I) EN DONDE R1 ES HIDROGENO O ALQUILO (C1©C4); R2 ES CN, COOH, COOR5, CONH2, CONHR5, CON(R5)R6, SR5, S(O)R5M S(O)2R5, CHO, CH2OH, COR7, CH2R7, CH(OH)R5, CH2CF3, TODO, CDCR8, CHDCHR8, ALQUILO (C2©C12), NO2, NH2 O NHCOR9; R3 ES ALQUILO (C1©C5) O ALQUENILO (C3©C5); Y R4 ES ALQUILO (C1©C12), CICLOALQUILO (C3©C7) O ADAMANTILO; O UNA SAL DE ADICION DE ACIDO DE DICHO COMPUESTO. COMPRENDE REACCIONAR UN COMPUESTO DE FORMULA (II) CON ISOCIANATO DE CLOROSULFONILO; O CON UN COMPUESTO R5SCL; O CON UN COMPUESTO R7CO©Y; O REACCIONAR UN COMPUESTO DE FORMULA (V) CON UN COMPUESTO CH2DCHRK8 O CHDCRK8. LOS COMPUESTOS (I) POSEEN ACTIVIDAD NEUROLEPTICA Y ANTIDEPRESIVA.PROCEDURE FOR PREPARING NEW 8 ALPHA © ACILAMINO © ERGOLINAS, OF FORMULA (I) WHERE R1 IS HYDROGEN OR ALKYL (C1 © C4); R2 ES CN, COOH, COOR5, CONH2, CONHR5, CON (R5) R6, SR5, S (O) R5M S (O) 2R5, CHO, CH2OH, COR7, CH2R7, CH (OH) R5, CH2CF3, TODO, CDCR8 , CHDCHR8, ALKYL (C2 © C12), NO2, NH2 OR NHCOR9; R3 IS ALKYL (C1 © C5) OR ALKYNYL (C3 © C5); AND R4 IS ALKYL (C1 © C12), CYCLLOALKYL (C3 © C7) OR ADAMANTILO; OR AN ACID ADDITION SALT OF SUCH A COMPOUND. UNDERSTANDS TO REACT A COMPOUND OF FORMULA (II) WITH CHLOROSULFONYL ISOCYANATE; OR WITH AN R5SCL COMPOUND; OR WITH A R7CO © Y COMPOUND; OR REACT A FORMULA COMPOUND (V) WITH A CH2DCHRK8 OR CHDCRK8 COMPOUND. COMPOUNDS (I) HAVE NEUROLEPTIC AND ANTI-DEPRESSIVE ACTIVITY.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3602058 | 1986-01-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2003774A6 true ES2003774A6 (en) | 1988-11-16 |
Family
ID=6292510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES8700163A Expired ES2003774A6 (en) | 1986-01-24 | 1987-01-22 | 8 alpha -Acylaminoergoline's |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS62190184A (en) |
| KR (1) | KR870007175A (en) |
| AU (1) | AU6791487A (en) |
| BE (1) | BE1000039A4 (en) |
| DK (1) | DK35787A (en) |
| ES (1) | ES2003774A6 (en) |
| FI (1) | FI870293A7 (en) |
| FR (1) | FR2595699A1 (en) |
| GB (1) | GB2185743A (en) |
| GR (1) | GR870093B (en) |
| HU (1) | HUT45248A (en) |
| IL (1) | IL81355A0 (en) |
| IT (1) | IT1216783B (en) |
| LU (1) | LU86743A1 (en) |
| NL (1) | NL8700046A (en) |
| PT (1) | PT84184A (en) |
| SE (1) | SE8700250L (en) |
| ZA (1) | ZA87520B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714767D0 (en) * | 1987-06-24 | 1987-07-29 | Erba Farmitalia | Egoline derivatives |
| DE3587860D1 (en) * | 1984-04-09 | 1994-07-28 | Schering Ag | 2-Substituted ergoline derivatives, process for their preparation and their use as medicines. |
| DK338789A (en) * | 1988-07-15 | 1990-01-16 | Schering Ag | 2-SUBSTITUTED ERGOLINYLURINE DERIVATIVES AND PROCEDURES FOR THE PRODUCTION THEREOF, THEIR USE AS MEDICINES AND INTERMEDIATES FOR THE PRODUCTION THEREOF |
| DE3915950A1 (en) * | 1989-05-12 | 1990-11-15 | Schering Ag | 8 (ALPHA) ACYLAMINO ERGOLINE, THEIR PRODUCTION AND USE AS A MEDICINAL PRODUCT |
| EP2723735A4 (en) * | 2011-06-23 | 2015-02-18 | Map Pharmaceuticals Inc | Novel fluoroergoline analogs |
| US8592445B2 (en) * | 2011-12-19 | 2013-11-26 | Map Pharmaceuticals, Inc. | Iso-ergoline derivatives |
| CN113149982A (en) | 2015-01-20 | 2021-07-23 | Xoc制药股份有限公司 | Ergoline compounds and uses thereof |
| JP2018502889A (en) * | 2015-01-20 | 2018-02-01 | エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ | Isoergoline compounds and uses thereof |
| BR112019025420A2 (en) | 2017-06-01 | 2020-06-16 | Xoc Pharmaceuticals, Inc. | POLYCYCLICAL COMPOUNDS AND USES OF THESE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1517973A (en) * | 1974-07-19 | 1978-07-19 | Sandoz Ltd | 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i |
| CH615929A5 (en) * | 1975-06-02 | 1980-02-29 | Sandoz Ag | Process for the preparation of novel ergoline compounds |
| HU197569B (en) * | 1984-01-12 | 1989-04-28 | Sandoz Ag | Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds |
-
1987
- 1987-01-12 NL NL8700046A patent/NL8700046A/en not_active Application Discontinuation
- 1987-01-12 HU HU8792A patent/HUT45248A/en unknown
- 1987-01-21 GB GB08701274A patent/GB2185743A/en not_active Withdrawn
- 1987-01-22 GR GR870093A patent/GR870093B/en unknown
- 1987-01-22 IL IL81355A patent/IL81355A0/en unknown
- 1987-01-22 FR FR8700834A patent/FR2595699A1/en active Pending
- 1987-01-22 IT IT8747551A patent/IT1216783B/en active
- 1987-01-22 DK DK035787A patent/DK35787A/en not_active Application Discontinuation
- 1987-01-22 AU AU67914/87A patent/AU6791487A/en not_active Abandoned
- 1987-01-22 KR KR870000556A patent/KR870007175A/en not_active Ceased
- 1987-01-22 PT PT84184A patent/PT84184A/en unknown
- 1987-01-22 LU LU86743A patent/LU86743A1/en unknown
- 1987-01-22 ES ES8700163A patent/ES2003774A6/en not_active Expired
- 1987-01-22 SE SE8700250A patent/SE8700250L/en not_active Application Discontinuation
- 1987-01-23 ZA ZA87520A patent/ZA87520B/en unknown
- 1987-01-23 BE BE8700046A patent/BE1000039A4/en not_active IP Right Cessation
- 1987-01-23 FI FI870293A patent/FI870293A7/en not_active IP Right Cessation
- 1987-01-23 JP JP62015028A patent/JPS62190184A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK35787D0 (en) | 1987-01-22 |
| GB8701274D0 (en) | 1987-02-25 |
| BE1000039A4 (en) | 1987-12-15 |
| GR870093B (en) | 1987-05-25 |
| JPS62190184A (en) | 1987-08-20 |
| PT84184A (en) | 1987-02-01 |
| SE8700250D0 (en) | 1987-01-22 |
| DK35787A (en) | 1987-07-25 |
| AU6791487A (en) | 1987-07-30 |
| GB2185743A (en) | 1987-07-29 |
| HUT45248A (en) | 1988-06-28 |
| SE8700250L (en) | 1987-07-25 |
| KR870007175A (en) | 1987-08-17 |
| FI870293A7 (en) | 1987-07-25 |
| LU86743A1 (en) | 1987-09-03 |
| NL8700046A (en) | 1987-08-17 |
| ZA87520B (en) | 1988-09-28 |
| IT1216783B (en) | 1990-03-14 |
| FI870293A0 (en) | 1987-01-23 |
| IT8747551A0 (en) | 1987-01-22 |
| FR2595699A1 (en) | 1987-09-18 |
| IL81355A0 (en) | 1987-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8705353A1 (en) | Dihydro and tetrahydroquinoline derivatives. | |
| ES2003774A6 (en) | 8 alpha -Acylaminoergoline's | |
| ES2033675T3 (en) | A PROCEDURE FOR PREPARING A N-BENZOIL UREA COMPOUND. | |
| ES2001698A6 (en) | Sulfonyl ureas with anti-tumour activity. | |
| FI872636A0 (en) | SUBSTITUERADE 4-BENSYL-PIPERAZINYLFOERENINGAR. | |
| CO4410185A1 (en) | NEW BENZAMIDINE, ITS PREPARATION AND ITS EMPLOYMENT AS A MEDICINE | |
| ES8704153A1 (en) | A PROCEDURE FOR PREPARING PIRIMIDINE DERIVATIVES | |
| ES8506655A1 (en) | Substituted phenylsulfonyl guanidine derivatives. | |
| ES2040222T3 (en) | PROCEDURE FOR PREPARING CERTAIN 2-BENZOIL-2,3,5-CYCLLOHEXANOTRIONAS. | |
| IT1202321B (en) | BIOLOGICALLY ACTIVE FLUORESCENT CYCLIC NUCLEOTIDES | |
| ES2043738T3 (en) | PROCEDURE FOR THE REDUCTION OF KETONES. | |
| ATE87661T1 (en) | DIABETIC COMPOUNDS. | |
| HU9400587D0 (en) | Herbicidal sulphonyl ureas, process and intermediates for producing the same | |
| FI860074A0 (en) | OKTAHYDROINDOLIZINFOERENINGAR ANVAENDBARA SOM SMAERTSTILLANDE MEDEL. | |
| SG58291G (en) | Anticonvulsant agents | |
| ES8504794A1 (en) | Quinazoline cardiac stimulants. | |
| IT1215251B (en) | PHARMACEUTICALS THAT CONTAIN THEM. ANTI-AGGREGATING PLATE COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND COMPOSITIONS | |
| IT1122376B (en) | DIURETIC PRODUCTS | |
| PH18629A (en) | Substituted 2,3-alkylene bis (oxy) benzoic acid derivatives | |
| ES548497A0 (en) | PROCEDURE FOR PREPARING 3-AMINO-2,3-DIHI-DRO-1-BENZOXEPINE COMPOUNDS | |
| JO1412B1 (en) | substituted 4- benzylpiperazinyl compounds | |
| ES468582A1 (en) | PROCEDURE FOR PRODUCING CEPHALOS-PORINIC THERAPEUTIC COMPOUNDS | |
| ES2000669A6 (en) | Pyrazole derivative and herbicide comprising same as active ingredient | |
| ES8602601A1 (en) | Brominated cyclohexyl-amino-methyl aniline | |
| SU997401A1 (en) | Ammonium salts of substituted phenylthioacetic acids with anti-inflammatory activity |